Free Trial
OTCMKTS:IMUC

EOM Pharmaceutical (IMUC) Stock Price, News & Analysis

EOM Pharmaceutical logo
$0.07 0.00 (0.00%)
As of 07/3/2025

About EOM Pharmaceutical Stock (OTCMKTS:IMUC)

Key Stats

Today's Range
$0.07
$0.07
50-Day Range
$0.06
$0.12
52-Week Range
$0.01
$0.21
Volume
N/A
Average Volume
459 shs
Market Capitalization
$8.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMUC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EOM Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

IMUC Stock News Headlines

Q32 Bio Inc. R (DB0.BE)
ImmunoCellular Therapeutics, Ltd. (IMUC)
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
EOM Pharmaceutical Holdings Inc.
Oramed Pharmaceuticals Inc ORMP
See More Headlines

IMUC Stock Analysis - Frequently Asked Questions

EOM Pharmaceutical's stock was trading at $0.1688 at the start of the year. Since then, IMUC shares have decreased by 57.9% and is now trading at $0.0711.

EOM Pharmaceutical Holdings, Inc. (OTCMKTS:IMUC) announced its earnings results on Monday, August, 13th. The company reported ($0.01) EPS for the quarter.

Shares of IMUC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that EOM Pharmaceutical investors own include Argos Therapeutics (ARGSQ), Nightfood (NGTF), Meta Platforms (META), LadRx (CYTR), Inovio Pharmaceuticals (INO), MannKind (MNKD) and Agenus (AGEN).

Company Calendar

Last Earnings
8/13/2018
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:IMUC
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
122,354,000
Market Cap
$8.99 million
Optionable
Not Optionable
Beta
-0.01
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (OTCMKTS:IMUC) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners